Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MediPharm LabsTSX:LABS Days Payable is 81.81 as of Jun. 2026, which is 94% above its 10-year median of 42.17. The stock has 4 warning signs investors should review. Among 925 Drug Manufacturers companies, MediPharm Labs ranks worse than 63.89% on this metric.
The historical data trend for MediPharm Labs's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MediPharm Labs Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's Days Payable distribution charts can be found below:
* The bar in red indicates where MediPharm Labs's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
MediPharm Labs's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MediPharm Labs (TSX:LABS) has a Days Payable of 81.81 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MediPharm Labs and its competitors. This is 94% above median its historical median of 42.17. Over the past decade, MediPharm Labs' Days Payable has ranged from 38.03 to 64.65. According to the industry distribution chart, MediPharm Labs ranks #591 out of 925 companies in the Drug Manufacturers industry, placing it in the top 63.9%.
Is MediPharm Labs' Days Payable too high?
MediPharm Labs' current Days Payable of 81.81 is 94% above median its 10-year median of 42.17. Over the past 10 years, this metric has ranged from a low of 38.03 to a high of 64.65. The Drug Manufacturers industry median Days Payable is 88.85. MediPharm Labs' value of 81.81 is 7.9% below this industry median. Based on the distribution chart, MediPharm Labs ranks #591 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does MediPharm Labs' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, MediPharm Labs ranks #591 out of 925 companies for Days Payable. This places MediPharm Labs in the lower half of its industry. The industry median Days Payable is 88.85. MediPharm Labs' value of 81.81 is 7.9% below this benchmark. Historically, MediPharm Labs' own Days Payable has ranged from 38.03 to 64.65 over the past decade. While the company's 10-year median is 42.17 vs. the industry median of 88.85, MediPharm Labs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.85, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MediPharm Labs's current Days Payable of 81.81 is 7.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MediPharm Labs and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MediPharm Labs's current Days Payable is 81.81, which is 94% above median its own 10-year median of 42.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediPharm Labs stock overvalued right now?
Based on GuruFocus' analysis, MediPharm Labs (TSX:LABS) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.07, compared to a current price of C$0.08 — trading 14.3% above its estimated fair value. The current Days Payable is 81.81, which is 94% above median its 10-year median of 42.17 and 7.9% below the Drug Manufacturers industry median of 88.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MediPharm Labs (TSX:LABS), the current Days Payable is 81.81 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MediPharm Labs Corp and its subsidiaries produce cannabis, purified and pharmaceutical-like cannabis extracts, related derivative products, and cannabis-related medical information and services. Its operating subsidiaries hold cultivation, standard processing, and sale licences under the Cannabis Act (Canada), allowing the cultivation, sale, and distribution of cannabis oil, extracts, edibles, topicals, dried and fresh cannabis, and derivatives to authorized purchasers. Its subsidiary provides clinic services to Canadian patients requiring medical cannabis education and prescriptions. The company operates in one reportable segment, the production and sales of cannabis flower, and generates maximum revenue from Canada, with additional international sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:LABS has been successfully added to your 
